ph+ Acute Lymphoblastic Leukemia
3 clinical trials · Condition
◉ Watch ph+ Acute Lymphoblastic Leukemia
| Record | Firm | Date |
|---|---|---|
| Study of Chemotherapy-Free Induction Regimen for Ph+ Acute Lymphoblastic Leukemia With Inotuzumab Ozogamicin (InO) (NCT04747912) | University of Chicago | 2021-03-02 |
| Low-dose Chemotherapy Combine With Tyrosine Kinase Inhibitor to Treat ph+ Acute Lymphoblastic Leukemia Patients (NCT02690922) | Tongji Hospital | 2016-03-01 |
| Ponatinib for Chronic Myeloid Leukemia (CML) Evaluation and Ph+ Acute Lymphoblastic Leukemia (ALL) (NCT01207440) | Ariad Pharmaceuticals | 2010-09-30 |
Track ph+ Acute Lymphoblastic Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.